(Q81297558)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15660473%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

The economics of follow-on drug research and development: trends in entry rates and the timing of development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15660473%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Joseph A DiMasi

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15660473%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Cherie Paquette

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15660473%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15660473%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15660473%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15660473%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

2 Suppl 2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15660473%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1-14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15660473%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00019053-200422002-00002

7 January 2020

exact match

0 references

cites work

The pharmaceutical industry--to whom is it accountable?

1 reference

12 December 2020

Risks in new drug development: approval success rates for investigational drugs

1 reference

12 December 2020

New drug development in the United States from 1963 to 1999

1 reference

12 December 2020

America's other drug problem: how the drug industry distorts medicine and politics

1 reference

12 December 2020

The price of innovation: new estimates of drug development costs

1 reference

12 December 2020

The changing structure of the pharmaceutical industry

1 reference

12 December 2020

"Me-too" products--friend or foe?

1 reference

12 December 2020

Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPS

1 reference

12 December 2020

Returns on research and development for 1990s new drug introductions

1 reference

12 December 2020

Scale, scope, and spillovers: the determinants of research productivity in drug discovery

1 reference

12 December 2020